In this randomized controlled trial, it was found that GA2, a late-arresting, genetically attenuated Plasmodium falciparum ...

The results of a clinical tria l into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection ...

The jab targets parasites after they pass through the liver and into the blood, which is the stage that causes symptoms ...

than with an early-arresting parasite (GA1), which indicates a potential role for late-liver-stage antigens in eliciting protective immunity to malaria. Protection was not associated with ...

A new malaria vaccine that tackles the infection at a different stage to those currently on offer has been shown to be “safe ...

The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers ...

An innovative malaria immunisation approach using genetically attenuated parasites has demonstrated promising efficacy. Read ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Malaria mortality has fallen back to levels seen before the Covid-19 crisis, the WHO said Wednesday, but called for faster ...

A new malaria vaccine appears to be "safe and highly immunogenic", with "promising efficacy", according to interim results of ...

For April 2023, Ghana become di first African kontri to approve di R21/Matrix-M vaccine, and since den, eight oda African ...

A new malaria vaccine that tackles the infection at a different stage to those currently on offer has been shown to be “safe and well tolerated” in clinical trials, an Oxford expert has said. It is ...